Transgene puts its best foot forward at first R&D day
This article was originally published in Scrip
Executive Summary
Transgene put two recent pipeline setbacks firmly behind it at its first ever R&D day last week, when the company outlined its plans to become a fully integrated biopharmaceutical company with an increasing presence in China.